Evidence map›Paper›PMID 40797027›Full record

ArticleScientific reports2025

Cohort profile of the Heidelberg study on diabetes and complications HEIST-DiC.

Elisabeth Kliemank, Ekaterina von Rauchhaupt, Lukas Seebauer, Mani Roshan, Malin Ansmann, Viktoria Flegka, Lukas Schimpfle, Dimitrios Tsilingiris, Hannelore Bartl, Thomas Fleming and 11 more

Registry-linked trialAbstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03022721 (Heidelberg Study on Diabetes and Complications), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03022721 recruitingnot on this map

Heidelberg Study on Diabetes and Complications

TypeobservationalSponsorHeidelberg UniversityRan2016 to 2028Enrolled500ConditionsDiabetes ComplicationsArmsNo interventions are planned for this study.
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Elisabeth KliemankDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Ekaterina von RauchhauptDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Lukas SeebauerDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Mani RoshanDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Malin AnsmannDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Viktoria FlegkaDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Lukas SchimpfleDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Dimitrios TsilingirisDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Hannelore BartlDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Thomas FlemingDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Zoltan KenderDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Johann M E JendeDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Christoph M MooshageDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Daniel SchwarzDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Martin BendszusDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Peter SchirmacherInstitute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Stephan HerzigGerman Center for Diabetes Research (DZD), München-Neuherberg, Germany.
Peter P NawrothDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Stefan KopfDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Julia SzendroediDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany.
Alba SulajDepartment of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), Heidelberg University Hospital, Heidelberg, Germany. Alba.Sulaj@med.uni-heidelberg.de.ORCID http://orcid.org/0000-0002-6051-6696

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Heidelberg Study on Diabetes and Complications (HEIST-DiC) is a prospective longitudinal study focused on the development and progression of diabetes-associated complications. Participants with/without diabetes mellitus undergo annual phenotyping of diabetes-associated complications over 11 years. Assessments include: albuminuria, estimated glomerular filtration rate for chronic kidney disease; clinical neuropathy scores, Purdue Pegboard test, electrophysiological examination, transcutaneous electrical nerve fiber stimulation, quantitative sensory testing and high-resolution magnetic resonance neurography for distal sensorimotor polyneuropathy; heart rate variability for cardiovascular autonomic neuropathy; funduscopic examination of undilated pupils for retinopathy; the 6-minute walk test, spirometry, body plethysmography, and carbon monoxide-based diffusing capacity measurements for respiratory lung disease; non-invasive scores, transient elastography and hepatic ultrasound for metabolic dysfunction-associated steatotic liver disease; ankle-brachial index and carotid intima-media thickness for peripheral atherosclerosis; hand grip strength for muscle function; bioelectrical impedance analysis for body composition; skin autofluorescence for measurement of advanced glycation end products. Beta-cell function and tissue-specific insulin sensitivity are evaluated using oral glucose tolerance test or euglycemic hyperinsulinemic clamp. The biobank stores specimens of blood, urine, skeletal muscle, subcutaneous adipose tissue, and skin. Health-related quality of life, physical health, and somatic and depression symptoms are measured via standardized questionnaires. HEIST-DiC explores diabetes onset in high-risk individuals, disease progression and the development of complications, aiming to design personalized strategies to prevent, mitigate, or reverse diabetes-related complications.Trial registration: The study was retrospectively registered at Clinicaltrials.gov (NCT03022721, date of registration 20170112).

Indexed as

Diabetes ComplicationsAdultAgedFemaleGermanyHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesDeep metabolic and clinical phenotypingDiabetes-associated complicationsIdentification of diabetes subtypes

Identifiers

PMID40797027
PMCPMC12343885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.